Update on Share Buyback program in H. Lundbeck A/S

	Release date: 23-05-2008
	Release time: 17:04

Lundbeck's Supervisory Board has acted on its authorization to acquire up to 10% of its shares. Under the program Lundbeck was to buy own shares for an amount of up to DKK 6 billion, cf. stock exchange announcement number 166 dated 17 August 2005.

The following transactions have been made under the program:

	No. of shares	Average purchase price (DKK)	Transaction value (DKK)
Accumulated, last announcement	30,195,584	133.5288	4,031,978,806
19 May 2008	16,800	127.3136	2,138,868.90
20 May 2008	99,000	125.7399	12,448,246.01
21 May 2008	8,400	124.0620	1,042,120.80
22 May 2008	--	--	--
23 May 2008	--	--	--
Accumulated under the program	30,319,784	133.4973	4,047,608,042

Following the above buyback it is hereby announced that Lundbeck owns a total of 11,162,997 own shares at a nominal value of DKK 5, equal to 5.39% of the total number of 207,279,631 shares.

Termination of Share Buyback program in Lundbeck

With reference to Lundbecks release no 343 of 22 May 2008, Lundbeck has decided to terminate its ongoing share buy back program in connection with the acquisition of the European rights for Flurizan®. Last day of trading was Thursday 21 May 2008.

Since the initiation of the share buy back program Lundbeck has publicly announced that it has been entitled to terminate the share buy back program at any time as a consequence of changes to the company's financial position or changes in the market for instance acquisitions or in-licensing opportunities.

Lundbeck contacts

Investors:	Media:

Jacob Tolstrup	Jens Harder Højbjerg
Director	Media Relations Manager
+45 36 43 30 79	+45 36 43 28 33

Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26

Stock Exchange Release No 345 - 23 May 2008

About Lundbeck

H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2007, the company's revenue was DKK 11 billion (approximately EUR 1.5 billion or USD 2.0 billion). The number of employees is approximately 5,300 globally. For further information, please visit www.lundbeck.com

Update on Share Buyback program in H. Lundbeck A/S

Read also